The round was led by Archangels, Par Equity, and Scottish Enterprise to accelerate product development and international growth.
"This investment reflects the growing recognition of the critical need for innovative communication solutions in the underwater IoT sector. The support from our investors will allow us to scale our operations, enhance our product offerings and help industries worldwide manage their resources more effectively. We are grateful for their trust and excited to shape the future of underwater communication."
Equity Gap led the seed financing for the Edinburgh based manufacturer of custom fit respirators, with backing from Scottish Enterprise, Old College Capital, and Apollo Informal Investment.
"We realised that by combining modern 3D imaging with 3D-printed soft materials, we could create bespoke, perfectly fitted masks that conform to the unique contours of each face. In our first comparative trial, our masks proved more comfortable than standard disposable alternatives. Since then, we’ve refined our design dramatically yet we’ve remained true to our original mission: to create the most comfortable, personalised respiratory masks possible, suited for every face. We believe the days of painful, pressure-inducing masks are finally over."
The investment round was led by Maven Capital Partners through the Investment Fund for Scotland alongside Scottish Enterprise.
"We are delighted to have secured this significant investment led by Maven, which highlights the strength of our technology and reinforces our vision for the future of water disinfection. This funding represents a tremendous opportunity to scale our operations, drive innovation through research and development, and deliver sustainable, cost-effective water treatment solutions to a growing global market."
The funding round was led by Equity Gap with co-investment from Scottish Enterprise and support from Lifted Ventures.
"Lifted Ventures immediately understood the challenges our product addresses for women and recognized the potential of the market we’re targeting. Their members are more than investors – they bring invaluable networks and skillsets that are often difficult to secure. I’ve been hugely impressed by their enthusiasm, capability, and commitment, especially in encouraging more female investors into equity investing."
The Edinburgh spinout will use the capital to launch new programmes and establish its operational footprint.
"We are so excited to be taking the next step in our spin-out journey and want to sincerely thank all the investors and supporters who have helped us make it happen. Our ambition is to be the go-to partner for gene control to make gene and cell therapies as safe as possible. This commitment from our investors, building on the ongoing support from Scottish Enterprise, speaks to the potential they see in our work, and we look forward to using the funding to further develop our technology."
